GHB leaves the bloodstream remarkably fast, with a plasma half-life of roughly 30 to 50 minutes, making it one of the most difficult recreational drugs to detect after the fact. In blood, GHB is typically undetectable above forensic thresholds within about four hours of ingestion. Urine stretches that window to roughly 8 to 12 hours in most adults, though individual variation can push it somewhat shorter or longer. The narrow detection window, combined with the fact that the body produces small amounts of GHB on its own, creates real challenges for anyone trying to confirm exposure.
Why GHB Vanishes So Quickly
GHB is metabolized almost entirely by the body rather than being excreted intact. Only about 1 to 5 percent of a dose ends up in urine as unchanged GHB; the rest is broken down, mainly through pathways that convert it into carbon dioxide and water via the citric acid cycle. Peak blood concentrations occur roughly 20 to 40 minutes after someone swallows a dose, and from there levels drop steeply. The plasma elimination half-life in healthy adults is in the range of about half an hour to just under an hour, depending on the study and the dose given. That means blood levels can halve multiple times in the span of a few hours, bringing them down to levels that are indistinguishable from what the body produces naturally.
This rapid metabolism is the core reason GHB is so hard to catch on a standard toxicology screen. Most hospital emergency departments do not routinely test for GHB, and by the time a patient is stable enough for blood to be drawn, concentrations may already have plummeted below detection thresholds.
Detection Windows by Sample Type
How long GHB shows up depends heavily on which body fluid is tested. Each matrix has its own window, its own strengths, and its own complications.
Blood and Plasma
Blood gives the shortest useful window. In a controlled study, GHB was detectable above common cutoff concentrations for only about four hours after ingestion. After that, levels fall back into the range the body produces on its own, and distinguishing an external dose from natural background becomes unreliable. One research group found that a downstream metabolite called 3,4-dihydroxybutyric acid (3,4-DHB) stayed elevated for up to 12 hours in blood plasma, which could eventually help extend the practical detection window, but this marker is not yet part of routine screening.1PubMed. Detection of γ-hydroxybutyric acid-related acids in blood plasma and urine: Extending the detection window of an exogenous γ-hydroxybutyric acid intake?
Urine
Urine offers a somewhat longer window because GHB continues to be filtered by the kidneys even as blood levels decline. In controlled dosing studies with therapeutic-level doses, peak urine concentrations averaged roughly 150 to 200 mg/L in the first few hours, then dropped quickly. At a cutoff of 10 mg/L, about 81 percent of urine samples collected between 6 and 12 hours were already below the threshold, and all samples collected after 12 hours were negative.2PubMed Central. GHB urine concentrations after single-dose administration in humans That finding led researchers to conclude the detection window in urine may actually be shorter than the frequently cited 12-hour figure for some people taking moderate doses.3Journal of Analytical Toxicology. GHB Urine Concentrations After Single-Dose Administration in Humans
A separate pharmacokinetic study measuring urine after a single oral dose found a detection window of about 720 minutes, or 12 hours, and confirmed that only around 1 percent of the dose was recoverable in urine as unchanged GHB.4Journal of Analytical Toxicology. Pharmacokinetics and Excretion of Gamma-Hydroxybutyrate (GHB) in Healthy Subjects For most practical purposes, you can think of the urine window as somewhere in the range of 6 to 12 hours after ingestion, with a lot of individual variability. Sampling urine extends the window by roughly 3 to 4 hours compared with blood alone.
Oral Fluid (Saliva)
Saliva testing is less commonly used but has been explored as a rapid, noninvasive screening option. GHB does appear in saliva after ingestion, and analytical methods exist that can detect it, but the detection window is generally similar to or slightly shorter than urine.5PubMed. Determination of γ-hydroxybutyric acid in saliva by capillary electrophoresis coupled with contactless conductivity and indirect UV absorbance detectors Endogenous GHB levels in oral fluid are higher and more variable than in blood, with placebo samples in one controlled trial ranging from 0.025 to 0.93 μg/mL.6PubMed Central. Endogenous Levels, Detection Time, and Symptoms of Gamma-Hydroxybutyric Acid: Results From a Placebo-Controlled Clinical Trial That wider natural range makes it harder to set a clean cutoff that reliably separates someone who took GHB from someone who did not.
Your Body Already Contains GHB
One of the trickiest aspects of GHB testing is that the substance exists naturally in the human body as a minor byproduct of brain metabolism. In a placebo-controlled clinical trial, participants who received no GHB at all had blood concentrations ranging from about 0.007 to 0.05 μg/mL, with urine levels up to about 0.41 μg/mL.6PubMed Central. Endogenous Levels, Detection Time, and Symptoms of Gamma-Hydroxybutyric Acid: Results From a Placebo-Controlled Clinical Trial These endogenous levels are tiny compared with what you would see after someone swallows a recreational dose, but they mean that simply detecting GHB in a sample is not proof of external use. The question is always whether the concentration is above a threshold that rules out natural production.
This is where forensic cutoff values come in, and there is ongoing debate about where to set them. A cutoff of 10 mg/L in urine has been widely used, but research has shown that roughly a quarter of post-mortem cases with no known GHB exposure exceeded that level, and about 6 percent reached 20 mg/L. Based on those findings, a cutoff of 30 mg/L has been recommended by some researchers as more reliable for distinguishing endogenous from exogenous GHB in urine.7PubMed Central. Complications in post-mortem GHB cut-off values in urine samples: A case report A similar 30 mg/L threshold has been suggested for post-mortem blood, urine, and cerebrospinal fluid when samples are properly handled.8PubMed. Endogenous gamma-hydroxybutyric acid (GHB) concentrations in post-mortem specimens and further recommendation for interpretative cut-offs Raising the cutoff improves specificity, meaning fewer false positives, but it also means a genuine exposure is more likely to be missed if the sample is collected late.
Factors That Extend or Shorten the Window
The detection windows described above assume a healthy adult metabolizing GHB under normal conditions. Several factors can shift the timeline.
Alcohol
Drinking alcohol around the same time as GHB appears to slow GHB’s clearance. A human study found that co-ingesting ethanol resulted in a roughly 29 percent longer elimination half-life for GHB, along with a 16 percent higher peak blood concentration, though these changes did not reach statistical significance in that particular trial.9PubMed Central. GHB and Ethanol Effects and Interactions in Humans Animal studies have confirmed the direction of the effect more clearly, showing that ethanol inhibits key metabolic pathways for GHB and significantly increases its half-life while reducing total clearance.10Biomedicine & Pharmacotherapy. Alcohol perturbed locomotor behavior, metabolism, and pharmacokinetics of gamma-hydroxybutyric acid in rats Since recreational GHB use frequently involves alcohol, the practical detection window may be somewhat longer in real-world scenarios than in controlled studies using GHB alone.
Liver Disease
The liver handles most of GHB’s metabolism, so liver impairment can dramatically slow elimination. A study of patients with cirrhosis found that their overall GHB exposure (measured as area under the curve) was at least double that of healthy controls given the same dose. The half-life climbed from about 22 minutes in healthy subjects to 32 minutes in cirrhotic patients without fluid buildup, and to 56 minutes in those with ascites.11PubMed. Effect of moderate or severe liver dysfunction on the pharmacokinetics of gamma-hydroxybutyric acid While these are still short in absolute terms, more than doubling the half-life means substantially higher and more prolonged blood levels, which both increases intoxication risk and extends the window during which GHB would be detectable.
Age and Dose
Standard detection windows are based on studies using moderate, therapeutic-level doses in younger or middle-aged adults. Higher doses produce higher peak concentrations, which naturally take longer to fall below the detection threshold. In one striking case, GHB was detected in the urine of an elderly woman more than 24 hours after ingestion, far beyond the typical 12-hour ceiling. The researchers attributed the extended window to the combination of age-related changes in drug metabolism and what appeared to be a very large dose.12PubMed Central. Extended Detection Window for Gamma-Hydroxybutyrate in the Urine of an Elderly Woman This case is notable because it suggests that the standard “12 hours or less” rule of thumb can meaningfully underestimate the detection window in older adults or after massive doses.
Hair Testing as a Longer-Term Option
When blood and urine windows have closed, hair is sometimes the only biological specimen that can document GHB exposure. As GHB circulates in the bloodstream, trace amounts are incorporated into the growing hair shaft. A controlled experiment in which a volunteer received a single oral dose demonstrated that even one exposure is detectable in hair when the strand is cut into very small segments and analyzed with sensitive mass spectrometry techniques.13PubMed. Testing for GHB in hair by GC/MS/MS after a single exposure. Application to document sexual assault
However, hair analysis for GHB is far from straightforward. Because endogenous GHB also gets into hair, the background signal is always present, and the challenge is spotting a spike above it. A more recent study developing a method for analyzing 2-mm hair segments found that in some alleged users, concentration peaks indicating a specific ingestion event could be identified, but in others the results were ambiguous.14PubMed. Single hair analysis for gamma-hydroxybutyric acid-Method optimization, validation, and application Hair testing is typically a forensic tool used weeks to months after the event, since it takes time for the drug-containing portion of hair to grow out past the scalp. It is not useful for acute detection but can be invaluable in legal investigations where the question is whether someone was exposed at all, not how recently.
GHB Precursors and What They Mean for Detection
GHB is not always consumed directly. Two common precursors, gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD), are legal industrial chemicals that the body rapidly converts into GHB after ingestion. The conversion happens fast, with a half-life of roughly one minute, so by the time a person feels the effects, the active substance in their blood is GHB itself. Toxicology screens detect GHB regardless of whether the person took GHB directly or swallowed one of its precursors.
That said, the rate of conversion from precursors is not perfectly identical to simply taking GHB, which can affect timing. A comparative study found that although equimolar doses of GHB, GBL, and 1,4-BD were expected to produce similar GHB levels, the drugs did not produce identical effects in practice, likely because the rate of metabolic conversion varies.15PubMed. Comparative study of equimolar doses of gamma-hydroxybutyrate (GHB), 1,4-butanediol (1,4-BD) and gamma-butyrolactone (GBL) on catalepsy after acute and chronic administration In theory, a precursor that converts more slowly could produce a slightly more gradual rise in GHB blood levels and potentially extend the tail end of the detection window by a small margin. In practice, the difference is unlikely to be large enough to matter for most testing scenarios.
Why Emergency Rooms Often Miss GHB
If you present to an emergency department after suspected GHB exposure, there is a real chance the drug will not be confirmed. Standard urine drug screens do not include GHB. Specific GHB assays exist but are not widely available outside of specialized toxicology or forensic labs. An emergency department study found that among patients suspected of GHB intoxication, serum levels in confirmed-positive cases ranged from about 62 to 255 mg/L, while those who tested negative were below 6.2 mg/L. Most of the positive patients had also consumed alcohol or other drugs.16PubMed. Detection of gamma hydroxybutyrate in emergency department: Nice to have or a valuable diagnostic tool?
Even when clinicians suspect GHB based on symptoms, their accuracy is limited. A study evaluating whether emergency physicians could diagnose GHB intoxication from clinical observations alone found they were right only about 63 percent of the time. They were better at ruling it out, with a negative predictive value around 92 percent, meaning that when doctors thought a patient had not taken GHB, they were usually correct. But when they suspected GHB was involved, about one in three of those judgments turned out to be wrong.17PubMed. Can emergency department clinicians diagnose gamma-hydroxybutyrate (GHB) intoxication based on clinical observations alone? The practical message is that clinical suspicion alone is unreliable, and timely sample collection for laboratory confirmation matters enormously given how quickly GHB disappears.
The Evidence Problem After Death
Interpreting GHB levels in post-mortem samples is even more complicated than in living people. After death, GHB concentrations rise in the body through natural fermentation and bacterial processes, sometimes substantially. Decomposition bacteria, particularly certain Pseudomonas species, appear capable of producing GHB in stored blood over time.18Forensic Science International. The possible influence of micro-organisms and putrefaction in the production of GHB in post-mortem biological fluid This post-mortem production means that finding elevated GHB in a deceased person does not automatically indicate the person took GHB before death.19Forensic Science International. Postmortem concentrations of gamma-hydroxybutyrate (GHB) in peripheral blood and brain tissue — Differentiating between postmortem formation and antemortem intake
How samples are stored after collection also affects measured concentrations. Research has shown that GHB levels in post-mortem blood stored at refrigerator temperature without a preservative like sodium fluoride can spike dramatically, rising as high as 100 mg/L over four months. Freezing the samples and adding sodium fluoride substantially inhibits this artificial production.20PubMed. Gamma-hydroxybutyric acid stability and formation in blood and urine Even in ante-mortem (living patient) samples, GHB levels degrade if not handled properly: urine specimens showed more than 10 percent loss after just three days at any storage temperature, and more than 25 percent loss after four weeks.21PubMed. Assessment of the stability of exogenous gamma hydroxybutyric acid (GHB) in stored blood and urine specimens
The choice of blood preservative matters as well. A 2024 study comparing different anticoagulant-preservative tubes found that fluoride/oxalate tubes held GHB levels far more stable than fluoride/citrate tubes, with only a tiny average increase over 28 days at refrigerator temperature compared with a much larger rise in fluoride/citrate tubes. Freezing at minus 20 degrees Celsius prevented any measurable change.22Forensic Science International. Determination of endogenous GHB in ante-mortem whole blood, urine, and oral fluid by LC–MS/MS: The effect of different additives and storage conditions on the stability of GHB in blood These details may sound procedural, but they have real consequences for anyone whose legal case depends on a GHB test result. A sample drawn at the right time but stored improperly can yield a misleading number in either direction.
Drug-Facilitated Assault and the Timing Gap
GHB’s rapid elimination is one reason it has been called a “date-rape drug,” and the timing gap between exposure and testing is the central obstacle for victims seeking forensic evidence. A review examining the prevalence of drugs in cases of suspected drug-facilitated sexual assault found that an important gap often exists between what victims report and what toxicology confirms, partly because biological detection windows are so short and partly because victims may not be in a position to seek testing promptly.23Forensic Science International: Synergy. The prevalence of selected licit and illicit drugs in drug facilitated sexual assaults
If someone suspects they have been given GHB without their knowledge, getting a urine sample collected as soon as physically possible is the single most important step. Every hour that passes reduces the chances of a positive result. Blood collection within the first few hours is ideal but less commonly available outside a hospital. If more than a day has passed, hair analysis becomes the best remaining option, though it requires several weeks for the affected hair to grow long enough to be collected and analyzed. Nails represent another alternative specimen with a longer retention window, though research on GHB in nails remains limited compared with hair studies.